SCHMERZ is a pivotal journal in the fields of anesthesiology, pain medicine, and clinical neurology, published by SPRINGER HEIDELBERG in Germany. With an ISSN of 0932-433X and an E-ISSN of 1432-2129, the journal is celebrated for its rigorous peer-reviewed articles contributing to the understanding and management of pain. Since its inception in 1987, SCHMERZ has developed an impressive readership, ranking in the Q3 category across multiple disciplines, including Anesthesiology and Pain Medicine, and Clinical Neurology. Operating within the 50th percentile for anesthesiology and the 32nd percentile in neurology, the journal stands as a critical resource for practitioners, researchers, and students engaging with current trends and advancements in pain research and treatment. While not currently offering open access options, SCHMERZ continues to strive toward disseminating high-quality research and fostering vital discussions in the management of pain. With a scope that aims to bridge clinical practices with scientific understanding, SCHMERZ invites contributions that will illuminate and advance the multifaceted nature of pain and its treatment.

Frontiers in Pain Research is a leading open-access journal published by FRONTIERS MEDIA SA in Switzerland, devoted exclusively to advancing our understanding of pain, its mechanisms, and management. With an E-ISSN of 2673-561X and a strong dedication to academic rigor, the journal has quickly gained recognition in the field, boasting significant standings in various categories: Q2 in Anesthesiology and Pain Medicine and Q1 in Health Professions (miscellaneous) as of 2023. This interdisciplinary journal aims to facilitate the dissemination of novel research findings and therapeutic insights, contributing to enhanced patient care and improved outcomes. It holds credible ranks such as 20th percentile in Health Professions and 66th in Anesthesiology, solidifying its role as a vital resource for researchers, healthcare professionals, and students. The journal is committed to providing unrestricted access to its published works to spark global collaboration and dialogue in the crucial area of pain research.

Journal of Endometriosis and Pelvic Pain Disorders, published by SAGE Publications Ltd, is a vital resource dedicated to advancing the understanding and management of endometriosis and associated pelvic pain disorders. With an ISSN of 2284-0265 and E-ISSN 2284-0273, this journal caters to a diverse audience of researchers, healthcare professionals, and students in the field of Obstetrics and Gynecology. It has a notable 2023 Scopus ranking of #139 out of 209 in its category, positioning it within the Q3 quartile based on its impact and contribution to the literature. The journal aims to publish cutting-edge research, reviews, and clinical guidelines that illuminate the complexities of endometriosis and enhance patient care. Available through various academic channels, it not only fosters scholarly discourse but also supports the academic community in addressing the challenges and advancements in the treatment of pelvic pain disorders. As the journal approaches its converged years from 2013 to 2024, it stands as a critical platform for disseminating impactful findings in a field that significantly affects women’s health globally.

IBRO Neuroscience Reports, published by Elsevier, is a pivotal open-access journal dedicated to advancing the field of neuroscience. With its ISSN 2667-2421, the journal serves as a vital platform for researchers, professionals, and students alike, showcasing innovative research and interdisciplinary studies that span various aspects of neuroscience. Since its inception in 2021, and with a planned convergence through 2024, the journal has quickly established itself within the academic community, currently holding a Q3 category ranking in the field of Neuroscience (miscellaneous) and a Scopus rank of #77 among 113 in General Neuroscience, reflecting its ongoing commitment to quality and relevance. The accessibility of research articles ensures that critical findings are widely disseminated, fostering collaboration and dialogue within the neuroscientific community. Researchers and professionals are encouraged to contribute to this dynamic journal, reinforcing its role in shaping the future of neuroscience research.

Neuropeptides is a prestigious, peer-reviewed journal published by Elsevier, focusing on the critical role of neuropeptides in various biological processes and their implications in cellular and molecular neuroscience, endocrinology, and neurology. With an impact factor reflecting its influence in the field and a diverse audience ranging from researchers to healthcare professionals, the journal serves as an essential platform for the dissemination of groundbreaking research from 1980 to 2024. Adhering to high academic standards, Neuropeptides holds a Q3 ranking in Cellular and Molecular Neuroscience and Endocrine and Autonomic Systems, alongside a solid Q2 ranking in both Endocrinology and Neurology. This positions the journal at the forefront of its disciplines, contributing valuable insights into the understanding of neuropeptide functions in health and disease. By not operating as an Open Access journal, it ensures sustainability in the publishing process while upholding rigorous review standards. Researchers, professionals, and students are encouraged to engage with the findings published in this journal, which plays a vital role in advancing knowledge and fostering collaboration within the neuroscientific community.

JOURNAL OF PAIN & PALLIATIVE CARE PHARMACOTHERAPY, published by Taylor & Francis Inc, is a vital resource for professionals in the fields of anesthesiology, pain medicine, and pharmacology. With an ISSN of 1536-0288 and an E-ISSN of 1536-0539, this esteemed journal has been providing a platform for innovative research and critical reviews since its inception in 2002, and it will continue to contribute to scientific discourse until 2024. Holding a Q2 ranking in Anesthesiology and Pain Medicine and a Q3 ranking in Medical Pharmacology, the journal is positioned to deliver high-impact articles that explore advancements in pain management and palliative care strategies. While not an Open Access journal, it offers significant subscription-based access to its curated content, ensuring that researchers and practitioners have the opportunity to stay updated on the latest trends and findings in pain therapy. Furthermore, with its Scopus rankings reflecting ongoing relevance and a robust academic community, this journal is essential for those aiming to deepen their understanding of pain management pharmacotherapy.

PAIN is a renowned academic journal published by Lippincott Williams & Wilkins, specializing in the critical fields of *Anesthesiology* and *Pain Medicine*, as well as *Neurology* and *Pharmacology*. With an ISSN of 0304-3959 and an E-ISSN of 1872-6623, this influential journal has established itself as a premier platform for disseminating key findings and advancements in pain research since its inception in 1975. Recognized for its high impact factor, PAIN holds a commendable Q1 ranking across multiple categories, including a ranking of #3 out of 136 in *Anesthesiology and Pain Medicine,* which showcases its pivotal role in the scientific community. The journal’s comprehensive scope encompasses empirical studies, reviews, and clinical insights, making it indispensable for researchers, clinicians, and students dedicated to understanding and treating pain. Although currently not offering open access, PAIN ensures that readers have access to cutting-edge research backed by rigorous peer-review processes. Join a vibrant community of professionals committed to enhancing the management of pain and advancing neuroscience by engaging with the invaluable resources provided by PAIN.

PAIN MEDICINE, published by Oxford University Press, is a leading journal in the disciplines of Anesthesiology and Pain Medicine. With its ISSN 1526-2375 and E-ISSN 1526-4637, this esteemed journal provides a platform for innovative research and clinical advancements in the field of pain management. With an impressive impact factor attributed to its Q1 ranking in both Anesthesiology and Pain Medicine as well as Q2 in Clinical Neurology for 2023, PAIN MEDICINE ensures high visibility and relevance within the scientific community, noted for its diverse contributions from across the globe. The journal's editorial mission focuses on disseminating significant findings that influence contemporary practices and policies in pain management. Scholars and practitioners are encouraged to engage with this vital resource, which shapes the future of pain medicine from its base at Great Clarendon St, Oxford, England, covering a remarkable timeline from 2000 to 2024.

The Journal of Neuroimmune Pharmacology, published by Springer, is a premier academic journal dedicated to advancing the field of pharmacology intersecting with neuroscience and immunology. With an outstanding impact factor and proudly positioned in the Q1 quartile across multiple categories, this journal showcases cutting-edge research that enhances our understanding of the neuroimmune system and its pharmacological implications. Established in 2006 and continuing through 2024, it serves as a vital resource for researchers, professionals, and students alike, offering insights into the mechanisms of drug action, disease processes, and therapeutic strategies. As a testament to its excellence, the journal ranks prominently in Scopus metrics within its discipline, making it an essential platform for disseminating high-quality research that drives innovation in immunology, allergy, neuroscience, and pharmacology.

Journal of Pain Research, published by DOVE MEDICAL PRESS LTD, stands at the forefront of the field of pain management and anesthesia, offering a critical platform for researchers and clinicians dedicated to advancing the understanding of pain and its treatment. With an Open Access model since 2008, this journal enhances accessibility to high-quality research, enabling a global audience to engage with innovative studies and findings. Recognized for its significant contributions, it has achieved a Q2 rank in Anesthesiology and Pain Medicine as of 2023, placing it among the top 30% in its category, and it holds a commendable Scopus rank of 41/136 in its field. Covering a broad scope encompassing clinical trials, pharmacology, and psychosocial aspects of pain, the journal invites submissions that advance both theoretical knowledge and practical applications, making it an invaluable resource for professionals, researchers, and students aiming to improve outcomes in pain management.